News

Doctoral candidate Amber Hazzard has been named one of 17 AAAS Mass Media Fellows for 2025.

Two Hollings Cancer Center researchers are studying new ways to bring depression treatment to cancer survivors.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Two women found friendship and solidarity as they go about their lives after a glioblastoma diagnosis.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

Children who do not meet inclusion criteria for current peds studies now have a chance through an innovative program.

Artificial intelligence (AI) has the potential to revolutionize the practice of dentistry, from real-time diagnostics to enhanced treatment planning.

MUSC study shows that long-acting antiretroviral therapy for persons living with HIV can be administered safely and effectively at home.

The Moodivate app improved depression symptoms significantly more than usual care treatment in a clinical trial at 22 MUSC Health primary care practices.

The Engevik sisters live for science – and they get to do it together at MUSC.